MRD Testing Market Size, Share, Trends, Growth and Forecast 2032
MRD Testing Market By End-User (Academic & Research Institutes, Diagnostic Laboratories, and Hospitals & Speciality Clinics), By Application (Solid Tumors and Hematological Malignancy), By Technology (Next Generation Sequencing (NGS), Flow Cytometry, Polymerase Chain Reaction (PCR), and Others), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2024 - 2032
Category: Healthcare Report Format : PDF
Pages: 217 Report Code: ZMR-8387
Published Date: Jun-2024 Status : Published
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 2,145.76 Million | USD 6,707.24 Million | 13.50% | 2023 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global MRD Testing Market, (2024 - 2032) (USD Million)
- 2.2 Global MRD Testing Market : snapshot
- Chapter 3. Global MRD Testing Market - Industry Analysis
- 3.1 MRD Testing Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Rising number of patients with cancer conditions may drive the market growth rate
- 3.3 Market Restraints
- 3.3.1. Limited application of the procedure at present times may restrict the market expansion rate
- 3.4 Market Opportunities
- 3.4.1. Steady growth in investments toward comprehensive growth of MRD testing may generate new expansion possibilities
- 3.5 Market Challenges
- 3.5.1. Concerns over the lack of sufficient medical reimbursements for MRD testing could challenge the expansion rate
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By End-User
- 3.7.2 Market attractiveness analysis By Application
- 3.7.3 Market attractiveness analysis By Technology
- Chapter 4. Global MRD Testing Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global MRD Testing Market: company market share, 2023
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global MRD Testing Market - End-User Analysis
- 5.1 Global MRD Testing Market overview: By End-User
- 5.1.1 Global MRD Testing Market share, By End-User, 2023 and 2032
- 5.2 Academic & Research Institutes
- 5.2.1 Global MRD Testing Market by Academic & Research Institutes, 2024 - 2032 (USD Million)
- 5.3 Diagnostic Laboratories
- 5.3.1 Global MRD Testing Market by Diagnostic Laboratories, 2024 - 2032 (USD Million)
- 5.4 Hospitals & Speciality Clinics
- 5.4.1 Global MRD Testing Market by Hospitals & Speciality Clinics, 2024 - 2032 (USD Million)
- 5.1 Global MRD Testing Market overview: By End-User
- Chapter 6. Global MRD Testing Market - Application Analysis
- 6.1 Global MRD Testing Market overview: By Application
- 6.1.1 Global MRD Testing Market share, By Application, 2023 and 2032
- 6.2 Solid Tumors
- 6.2.1 Global MRD Testing Market by Solid Tumors, 2024 - 2032 (USD Million)
- 6.3 Hematological Malignancy
- 6.3.1 Global MRD Testing Market by Hematological Malignancy, 2024 - 2032 (USD Million)
- 6.1 Global MRD Testing Market overview: By Application
- Chapter 7. Global MRD Testing Market - Technology Analysis
- 7.1 Global MRD Testing Market overview: By Technology
- 7.1.1 Global MRD Testing Market share, By Technology, 2023 and 2032
- 7.2 Next Generation Sequencing (NGS)
- 7.2.1 Global MRD Testing Market by Next Generation Sequencing (NGS), 2024 - 2032 (USD Million)
- 7.3 Flow Cytometry
- 7.3.1 Global MRD Testing Market by Flow Cytometry, 2024 - 2032 (USD Million)
- 7.4 Polymerase Chain Reaction (PCR)
- 7.4.1 Global MRD Testing Market by Polymerase Chain Reaction (PCR), 2024 - 2032 (USD Million)
- 7.1 Global MRD Testing Market overview: By Technology
- Chapter 8. MRD Testing Market - Regional Analysis
- 8.1 Global MRD Testing Market Regional Overview
- 8.2 Global MRD Testing Market Share, by Region, 2023 & 2032 (USD Million)
- 8.3. North America
- 8.3.1 North America MRD Testing Market, 2024 - 2032 (USD Million)
- 8.3.1.1 North America MRD Testing Market, by Country, 2024 - 2032 (USD Million)
- 8.3.1 North America MRD Testing Market, 2024 - 2032 (USD Million)
- 8.4 North America MRD Testing Market, by End-User, 2024 - 2032
- 8.4.1 North America MRD Testing Market, by End-User, 2024 - 2032 (USD Million)
- 8.5 North America MRD Testing Market, by Application, 2024 - 2032
- 8.5.1 North America MRD Testing Market, by Application, 2024 - 2032 (USD Million)
- 8.6 North America MRD Testing Market, by Technology, 2024 - 2032
- 8.6.1 North America MRD Testing Market, by Technology, 2024 - 2032 (USD Million)
- 8.4. Europe
- 8.4.2 Europe MRD Testing Market, 2024 - 2032 (USD Million)
- 8.4.2.1 Europe MRD Testing Market, by Country, 2024 - 2032 (USD Million)
- 8.4.2 Europe MRD Testing Market, 2024 - 2032 (USD Million)
- 8.4 Europe MRD Testing Market, by End-User, 2024 - 2032
- 8.4.1 Europe MRD Testing Market, by End-User, 2024 - 2032 (USD Million)
- 8.5 Europe MRD Testing Market, by Application, 2024 - 2032
- 8.5.1 Europe MRD Testing Market, by Application, 2024 - 2032 (USD Million)
- 8.6 Europe MRD Testing Market, by Technology, 2024 - 2032
- 8.6.1 Europe MRD Testing Market, by Technology, 2024 - 2032 (USD Million)
- 8.5. Asia Pacific
- 8.5.3 Asia Pacific MRD Testing Market, 2024 - 2032 (USD Million)
- 8.5.3.1 Asia Pacific MRD Testing Market, by Country, 2024 - 2032 (USD Million)
- 8.5.3 Asia Pacific MRD Testing Market, 2024 - 2032 (USD Million)
- 8.4 Asia Pacific MRD Testing Market, by End-User, 2024 - 2032
- 8.4.1 Asia Pacific MRD Testing Market, by End-User, 2024 - 2032 (USD Million)
- 8.5 Asia Pacific MRD Testing Market, by Application, 2024 - 2032
- 8.5.1 Asia Pacific MRD Testing Market, by Application, 2024 - 2032 (USD Million)
- 8.6 Asia Pacific MRD Testing Market, by Technology, 2024 - 2032
- 8.6.1 Asia Pacific MRD Testing Market, by Technology, 2024 - 2032 (USD Million)
- 8.6. Latin America
- 8.6.4 Latin America MRD Testing Market, 2024 - 2032 (USD Million)
- 8.6.4.1 Latin America MRD Testing Market, by Country, 2024 - 2032 (USD Million)
- 8.6.4 Latin America MRD Testing Market, 2024 - 2032 (USD Million)
- 8.4 Latin America MRD Testing Market, by End-User, 2024 - 2032
- 8.4.1 Latin America MRD Testing Market, by End-User, 2024 - 2032 (USD Million)
- 8.5 Latin America MRD Testing Market, by Application, 2024 - 2032
- 8.5.1 Latin America MRD Testing Market, by Application, 2024 - 2032 (USD Million)
- 8.6 Latin America MRD Testing Market, by Technology, 2024 - 2032
- 8.6.1 Latin America MRD Testing Market, by Technology, 2024 - 2032 (USD Million)
- 8.7. The Middle-East and Africa
- 8.7.5 The Middle-East and Africa MRD Testing Market, 2024 - 2032 (USD Million)
- 8.7.5.1 The Middle-East and Africa MRD Testing Market, by Country, 2024 - 2032 (USD Million)
- 8.7.5 The Middle-East and Africa MRD Testing Market, 2024 - 2032 (USD Million)
- 8.4 The Middle-East and Africa MRD Testing Market, by End-User, 2024 - 2032
- 8.4.1 The Middle-East and Africa MRD Testing Market, by End-User, 2024 - 2032 (USD Million)
- 8.5 The Middle-East and Africa MRD Testing Market, by Application, 2024 - 2032
- 8.5.1 The Middle-East and Africa MRD Testing Market, by Application, 2024 - 2032 (USD Million)
- 8.6 The Middle-East and Africa MRD Testing Market, by Technology, 2024 - 2032
- 8.6.1 The Middle-East and Africa MRD Testing Market, by Technology, 2024 - 2032 (USD Million)
- Chapter 9. Company Profiles
- 9.1 Sysmex Corporation
- 9.1.1 Overview
- 9.1.2 Financials
- 9.1.3 Product Portfolio
- 9.1.4 Business Strategy
- 9.1.5 Recent Developments
- 9.2 Bio-Techne Corporation
- 9.2.1 Overview
- 9.2.2 Financials
- 9.2.3 Product Portfolio
- 9.2.4 Business Strategy
- 9.2.5 Recent Developments
- 9.3 Adaptive Biotechnologies Corporation
- 9.3.1 Overview
- 9.3.2 Financials
- 9.3.3 Product Portfolio
- 9.3.4 Business Strategy
- 9.3.5 Recent Developments
- 9.4 Foundation Medicine Inc. (a member of the Roche Group)
- 9.4.1 Overview
- 9.4.2 Financials
- 9.4.3 Product Portfolio
- 9.4.4 Business Strategy
- 9.4.5 Recent Developments
- 9.5 NeoGenomics Laboratories Inc.
- 9.5.1 Overview
- 9.5.2 Financials
- 9.5.3 Product Portfolio
- 9.5.4 Business Strategy
- 9.5.5 Recent Developments
- 9.6 Guardant Health Inc.
- 9.6.1 Overview
- 9.6.2 Financials
- 9.6.3 Product Portfolio
- 9.6.4 Business Strategy
- 9.6.5 Recent Developments
- 9.7 Invivoscribe Inc.
- 9.7.1 Overview
- 9.7.2 Financials
- 9.7.3 Product Portfolio
- 9.7.4 Business Strategy
- 9.7.5 Recent Developments
- 9.8 F. Hoffmann-La Roche Ltd.
- 9.8.1 Overview
- 9.8.2 Financials
- 9.8.3 Product Portfolio
- 9.8.4 Business Strategy
- 9.8.5 Recent Developments
- 9.9 Illumina Inc.
- 9.9.1 Overview
- 9.9.2 Financials
- 9.9.3 Product Portfolio
- 9.9.4 Business Strategy
- 9.9.5 Recent Developments
- 9.10 Thermo Fisher Scientific Inc.
- 9.10.1 Overview
- 9.10.2 Financials
- 9.10.3 Product Portfolio
- 9.10.4 Business Strategy
- 9.10.5 Recent Developments
- 9.11 Genomic Health (acquired by Exact Sciences Corporation)
- 9.11.1 Overview
- 9.11.2 Financials
- 9.11.3 Product Portfolio
- 9.11.4 Business Strategy
- 9.11.5 Recent Developments
- 9.12 Natera Inc.
- 9.12.1 Overview
- 9.12.2 Financials
- 9.12.3 Product Portfolio
- 9.12.4 Business Strategy
- 9.12.5 Recent Developments
- 9.13 ArcherDX (now part of Invitae Corporation)
- 9.13.1 Overview
- 9.13.2 Financials
- 9.13.3 Product Portfolio
- 9.13.4 Business Strategy
- 9.13.5 Recent Developments
- 9.14 Bio-Rad Laboratories Inc.
- 9.14.1 Overview
- 9.14.2 Financials
- 9.14.3 Product Portfolio
- 9.14.4 Business Strategy
- 9.14.5 Recent Developments
- 9.15 Qiagen N.V.
- 9.15.1 Overview
- 9.15.2 Financials
- 9.15.3 Product Portfolio
- 9.15.4 Business Strategy
- 9.15.5 Recent Developments
- 9.16 and others.
- 9.16.1 Overview
- 9.16.2 Financials
- 9.16.3 Product Portfolio
- 9.16.4 Business Strategy
- 9.16.5 Recent Developments
- 9.1 Sysmex Corporation
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global MRD Testing Market, 2024 - 2032 (USD Million)
- 4. Porter’s Five Forces Analysis
- 5. Global MRD Testing Market attractiveness, By End-User
- 6. Global MRD Testing Market attractiveness, By Application
- 7. Global MRD Testing Market attractiveness, By Technology
- 8. Global MRD Testing Market share by End-User, 2024 and 2032 (USD Million)
- 9. Global MRD Testing Market by Academic & Research Institutes, 2024 - 2032 (USD Million)
- 10. Global MRD Testing Market by Diagnostic Laboratories, 2024 - 2032 (USD Million)
- 11. Global MRD Testing Market by Hospitals & Speciality Clinics, 2024 - 2032 (USD Million)
- 12. Global MRD Testing Market share by Application, 2024 and 2032 (USD Million)
- 13. Global MRD Testing Market by Solid Tumors, 2024 - 2032 (USD Million)
- 14. Global MRD Testing Market by Hematological Malignancy, 2024 - 2032 (USD Million)
- 15. Global MRD Testing Market share by Technology, 2024 and 2032 (USD Million)
- 16. Global MRD Testing Market by Next Generation Sequencing (NGS), 2024 - 2032 (USD Million)
- 17. Global MRD Testing Market by Flow Cytometry, 2024 - 2032 (USD Million)
- 18. Global MRD Testing Market by Polymerase Chain Reaction (PCR), 2024 - 2032 (USD Million)
- 19. Global MRD Testing Market share, by Region, 2024 and 2032
- 20. North America MRD Testing Market, 2024 - 2032 (USD Million)
- 21. Europe MRD Testing Market, 2024 - 2032 (USD Million)
- 22. Asia Pacific MRD Testing Market, 2024 - 2032 (USD Million)
- 23. Latin America MRD Testing Market, 2024 - 2032 (USD Million)
- 24. The Middle-East and Africa MRD Testing Market, 2024 - 2032 (USD Million)
Table Of Tables
- 1. Global MRD Testing Market: Snapshot
- 2. Drivers of the MRD Testing Market: impact analysis
- 3. North America MRD Testing Market revenue, By End-User, 2024 - 2032 (USD Million)
- 4. North America MRD Testing Market revenue, By Application, 2024 - 2032 (USD Million)
- 5. North America MRD Testing Market revenue, By Technology, 2024 - 2032 (USD Million)
- 6. U.S. MRD Testing Market revenue, By End-User, 2024 - 2032 (USD Million)
- 7. U.S. MRD Testing Market revenue, By Application, 2024 - 2032 (USD Million)
- 8. U.S. MRD Testing Market revenue, By Technology, 2024 - 2032 (USD Million)
- 9. Canada MRD Testing Market revenue, By End-User, 2024 - 2032 (USD Million)
- 10. Canada MRD Testing Market revenue, By Application, 2024 - 2032 (USD Million)
- 11. Canada MRD Testing Market revenue, By Technology, 2024 - 2032 (USD Million)
- 12. Europe MRD Testing Market revenue, By End-User, 2024 - 2032 (USD Million)
- 13. Europe MRD Testing Market revenue, By Application, 2024 - 2032 (USD Million)
- 14. Europe MRD Testing Market revenue, By Technology, 2024 - 2032 (USD Million)
- 15. Germany MRD Testing Market revenue, By End-User, 2024 - 2032 (USD Million)
- 16. Germany MRD Testing Market revenue, By Application, 2024 - 2032 (USD Million)
- 17. Germany MRD Testing Market revenue, By Technology, 2024 - 2032 (USD Million)
- 18. France MRD Testing Market revenue, By End-User, 2024 - 2032 (USD Million)
- 19. France MRD Testing Market revenue, By Application, 2024 - 2032 (USD Million)
- 20. France MRD Testing Market revenue, By Technology, 2024 - 2032 (USD Million)
- 21. U.K. MRD Testing Market revenue, By End-User, 2024 - 2032 (USD Million)
- 22. U.K. MRD Testing Market revenue, By Application, 2024 - 2032 (USD Million)
- 23. U.K. MRD Testing Market revenue, By Technology, 2024 - 2032 (USD Million)
- 24. Italy MRD Testing Market revenue, By End-User, 2024 - 2032 (USD Million)
- 25. Italy MRD Testing Market revenue, By Application, 2024 - 2032 (USD Million)
- 26. Italy MRD Testing Market revenue, By Technology, 2024 - 2032 (USD Million)
- 27. Spain MRD Testing Market revenue, By End-User, 2024 - 2032 (USD Million)
- 28. Spain MRD Testing Market revenue, By Application, 2024 - 2032 (USD Million)
- 29. Spain MRD Testing Market revenue, By Technology, 2024 - 2032 (USD Million)
- 30. Rest of Europe MRD Testing Market revenue, By End-User, 2024 - 2032 (USD Million)
- 31. Rest of Europe MRD Testing Market revenue, By Application, 2024 - 2032 (USD Million)
- 32. Rest of Europe MRD Testing Market revenue, By Technology, 2024 - 2032 (USD Million)
- 33. Asia Pacific MRD Testing Market revenue, By End-User, 2024 - 2032 (USD Million)
- 34. Asia Pacific MRD Testing Market revenue, By Application, 2024 - 2032 (USD Million)
- 35. Asia Pacific MRD Testing Market revenue, By Technology, 2024 - 2032 (USD Million)
- 36. China MRD Testing Market revenue, By End-User, 2024 - 2032 (USD Million)
- 37. China MRD Testing Market revenue, By Application, 2024 - 2032 (USD Million)
- 38. China MRD Testing Market revenue, By Technology, 2024 - 2032 (USD Million)
- 39. Japan MRD Testing Market revenue, By End-User, 2024 - 2032 (USD Million)
- 40. Japan MRD Testing Market revenue, By Application, 2024 - 2032 (USD Million)
- 41. Japan MRD Testing Market revenue, By Technology, 2024 - 2032 (USD Million)
- 42. India MRD Testing Market revenue, By End-User, 2024 - 2032 (USD Million)
- 43. India MRD Testing Market revenue, By Application, 2024 - 2032 (USD Million)
- 44. India MRD Testing Market revenue, By Technology, 2024 - 2032 (USD Million)
- 45. South Korea MRD Testing Market revenue, By End-User, 2024 - 2032 (USD Million)
- 46. South Korea MRD Testing Market revenue, By Application, 2024 - 2032 (USD Million)
- 47. South Korea MRD Testing Market revenue, By Technology, 2024 - 2032 (USD Million)
- 48. South-East Asia MRD Testing Market revenue, By End-User, 2024 - 2032 (USD Million)
- 49. South-East Asia MRD Testing Market revenue, By Application, 2024 - 2032 (USD Million)
- 50. South-East Asia MRD Testing Market revenue, By Technology, 2024 - 2032 (USD Million)
- 51. Rest of Asia Pacific MRD Testing Market revenue, By End-User, 2024 - 2032 (USD Million)
- 52. Rest of Asia Pacific MRD Testing Market revenue, By Application, 2024 - 2032 (USD Million)
- 53. Rest of Asia Pacific MRD Testing Market revenue, By Technology, 2024 - 2032 (USD Million)
- 54. Latin America MRD Testing Market revenue, By End-User, 2024 - 2032 (USD Million)
- 55. Latin America MRD Testing Market revenue, By Application, 2024 - 2032 (USD Million)
- 56. Latin America MRD Testing Market revenue, By Technology, 2024 - 2032 (USD Million)
- 57. Brazil MRD Testing Market revenue, By End-User, 2024 - 2032 (USD Million)
- 58. Brazil MRD Testing Market revenue, By Application, 2024 - 2032 (USD Million)
- 59. Brazil MRD Testing Market revenue, By Technology, 2024 - 2032 (USD Million)
- 60. Mexico MRD Testing Market revenue, By End-User, 2024 - 2032 (USD Million)
- 61. Mexico MRD Testing Market revenue, By Application, 2024 - 2032 (USD Million)
- 62. Mexico MRD Testing Market revenue, By Technology, 2024 - 2032 (USD Million)
- 63. Rest of Latin America MRD Testing Market revenue, By End-User, 2024 - 2032 (USD Million)
- 64. Rest of Latin America MRD Testing Market revenue, By Application, 2024 - 2032 (USD Million)
- 65. Rest of Latin America MRD Testing Market revenue, By Technology, 2024 - 2032 (USD Million)
- 66. The Middle-East and Africa MRD Testing Market revenue, By End-User, 2024 - 2032 (USD Million)
- 67. The Middle-East and Africa MRD Testing Market revenue, By Application, 2024 - 2032 (USD Million)
- 68. The Middle-East and Africa MRD Testing Market revenue, By Technology, 2024 - 2032 (USD Million)
- 69. GCC Countries MRD Testing Market revenue, By End-User, 2024 - 2032 (USD Million)
- 70. GCC Countries MRD Testing Market revenue, By Application, 2024 - 2032 (USD Million)
- 71. GCC Countries MRD Testing Market revenue, By Technology, 2024 - 2032 (USD Million)
- 72. South Africa MRD Testing Market revenue, By End-User, 2024 - 2032 (USD Million)
- 73. South Africa MRD Testing Market revenue, By Application, 2024 - 2032 (USD Million)
- 74. South Africa MRD Testing Market revenue, By Technology, 2024 - 2032 (USD Million)
- 75. Rest of Middle-East Africa MRD Testing Market revenue, By End-User, 2024 - 2032 (USD Million)
- 76. Rest of Middle-East Africa MRD Testing Market revenue, By Application, 2024 - 2032 (USD Million)
- 77. Rest of Middle-East Africa MRD Testing Market revenue, By Technology, 2024 - 2032 (USD Million)
Methodology
FrequentlyAsked Questions
MRD testing is also known as minimal or measurable residual disease testing.
The global MRD testing market is expected to generate higher growth due to the increasing number of patients who are currently living with cancer.
According to study, the global MRD testing market size was worth around USD 2,145.76 million in 2023 and is predicted to grow to around USD 6,707.24 million by 2032.
The CAGR value of MRD testing market is expected to be around 13.50% during 2024-2032.
The global MRD testing market will be dominated by North America during the projection period.
The global MRD testing market is led by players like Sysmex Corporation, Bio-Techne Corporation, Adaptive Biotechnologies Corporation, Foundation Medicine, Inc. (a member of the Roche Group), NeoGenomics Laboratories, Inc., Guardant Health, Inc., Invivoscribe, Inc., F. Hoffmann-La Roche Ltd., Illumina, Inc., Thermo Fisher Scientific Inc., Genomic Health (acquired by Exact Sciences Corporation), Natera, Inc., ArcherDX (now part of Invitae Corporation), Bio-Rad Laboratories, Inc. and Qiagen N.V.
The report explores crucial aspects of the MRD testing market including detailed discussion of existing growth factors and restraints while also browsing future growth opportunities and challenges that impact the market.
HappyClients
